ExpreS2ion Biotech: Pipeline focus on HER2+ breast cancer therapy
10 juni, 08:57
10 juni, 08:57
ExpreS2ion Biotech: Pipeline focus on HER2+ breast cancer therapy
10 juni, 08:57
ExpreS2ion Biotech: Pipeline focus on HER2+ breast cancer therapy
Veckans analyser
Fortnox-budet
Veckans analyser
Fortnox-budet
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 459,61